Read Time:8 Second
10/20/2021-Novavax’s stock fell 15% in volatile trading after a report was released claiming Novavax was running into trouble manufacturing a Covid-19 vaccine.
10/20/2021-Novavax’s stock fell 15% in volatile trading after a report was released claiming Novavax was running into trouble manufacturing a Covid-19 vaccine.
Average Rating
More Stories
MLS Games (3/29/2025)
NCAA Men’s Basketball Tournament (Elite 8 Round) (3/29/2025)
AEW Collision (3/29/2025)